Table 2.
Univariate model of patients' clinical data with progression-free survival (PFS) and overall survival (OS). The number of patients is 90 for both PFS and OS, whereas the number of events is 28 and 25, respectively.
| p value | HR | 95% CI for HR | ||
|---|---|---|---|---|
| Lower | Upper | |||
| Univariate Cox regression for PFS | ||||
| Gender (F vs M) | 0.698 | 1.196 | 0.485 | 2.951 |
| Age | 0.099 | 1.027 | 0.995 | 1.060 |
| Stage (III vs IV) | 0.197 | 1.758 | 0.747 | 4.137 |
| Tumor site (oroph vs other) | 0.914 | 1.043 | 0.488 | 2.227 |
| CHT (No vs Yes) | 0.101 | 0.470 | 0.190 | 1.159 |
|
| ||||
| Univariate Cox regression for OS | ||||
| Gender (F vs M) | 0.038 | 8.495 | 1.149 | 62.820 |
| Age | 0.004 | 1.052 | 1.016 | 1.089 |
| Stage (III vs IV) | 0.169 | 2.010 | 0.797 | 5.070 |
| Tumor site (oropharynx vs others) | 0.772 | 0.886 | 0.391 | 2.009 |
| CHT (No vs Yes) | 0.838 | 0.895 | 0.307 | 2.608 |